Protein aggregation in Huntington's disease

被引:43
作者
Hoffner, G [1 ]
Djian, P [1 ]
机构
[1] Univ Paris 05, Inst Interdisciplinaire Sci Vivant St Peres, CNRS, UPR 2228, 45 Rue St Peres, F-75270 Paris 6, France
关键词
aggregates; inclusions; Huntington's disease; polyglutamine;
D O I
10.1016/S0300-9084(02)01398-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The presence of an expanded polyglutamine produces a toxic gain of function in huntingtin. Protein aggregation resulting from this gain of function is likely to be the cause of neuronal death. Two main mechanisms of aggregation have been proposed: hydrogen bonding by polar-zipper formation and covalent bonding by transglutaminase-catalyzed cross-linking. In cell culture models of Huntington's disease, aggregates are mostly stabilized by hydrogen bonds, but covalent bonds are also likely to occur. Nothing is known about the nature of the bonds that stabilize the aggregates in the brain of patients with Huntington's disease. It seems that the nature of the bond stabilizing the aggregates is one of the most important questions, as the answer would condition the therapeutic approach to Huntington's disease. (C) 2002 Societe francaise de biochimie et biologie moleculaire/Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 44 条
[1]   Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length [J].
Becher, MW ;
Kotzuk, JA ;
Sharp, AH ;
Davies, SW ;
Bates, GP ;
Price, DL ;
Ross, CA .
NEUROBIOLOGY OF DISEASE, 1998, 4 (06) :387-397
[2]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[3]   Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin [J].
Boutell, JM ;
Thomas, P ;
Neal, JW ;
Weston, VJ ;
Duce, J ;
Harper, PS ;
Jones, AL .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1647-1655
[4]   Tissue transglutaminase does not contribute to the formation of mutant Huntingtin aggregates [J].
Chun, WJ ;
Lesort, M ;
Tucholski, J ;
Ross, CA ;
Johnson, GVW .
JOURNAL OF CELL BIOLOGY, 2001, 153 (01) :25-34
[5]   Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length [J].
Cooper, AJL ;
Sheu, KFR ;
Burke, JR ;
Onodera, O ;
Stritmatter, WJ ;
Roses, AD ;
Blass, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (23) :12604-12609
[6]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[7]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[8]   Mutant protein in Huntington disease is resistant to proteolysis in affected brain [J].
Dyer, RB ;
McMurray, CT .
NATURE GENETICS, 2001, 29 (03) :270-278
[9]   Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains:: A possible mechanism contributing to CAG-triplet diseases [J].
Gentile, V ;
Sepe, C ;
Calvani, M ;
Melone, MAB ;
Cotrufo, R ;
Cooper, AJL ;
Blass, JP ;
Peluso, G .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 352 (02) :314-321
[10]   TRANSGLUTAMINASE ACTIVITY IN RAT-BRAIN - CHARACTERIZATION, DISTRIBUTION, AND CHANGES WITH AGE [J].
GILAD, GM ;
VARON, LE .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (05) :1522-1526